COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.

Real-World Data at COTA

Patient health data is at the core of almost every healthcare technology innovation. Collected and stored across computers, mobile devices, wearables, and other technologies, this data, collectively, is called real-world data (RWD). This page serves as a library of how we see RWD driving value in the cancer space.

Why use Real-World Data?

At COTA, we curate regulatory-grade oncology RWD with the most relevance for our life sciences and provider partners, whether that involves supporting regulatory filings or research questions.  We cannot unlock the full value of RWD without the highest-quality collection and curation methodology, and we are powering a revolution in the development of new cancer therapies to bring clarity to cancer care.


How we define regulatory-grade data:


  • COTA oversees the entire process from abstraction of raw data to final delivery of curated RWD
  • Traceability of all our data: where it originates, the transformations applied, and QA checks along the way


  • The right cohorts after applying inclusion/exclusion criteria at the right volumes

  • Representativeness across real-world and clinical trial populations

  • Coverage across geographies of interest


  • Faithful representation of the original clinical data documented in EHR
  • Technology-enabled human abstraction leveraged to understand and capture clinical nuances
  • Accuracy of capture ensured through documented, multi-step QA/QC process

We have a responsibility to drive the use of RWD by consistently improving our data and demonstrating its utility. Our data has been used to support FDA and EMA submissions, explain care patterns, understand patient outcomes, and much more – and we anticipate the number of use cases to multiply in the coming years as RWD is explored and leveraged by more and more innovators in the industry.

Request a Demo

  • This field is for validation purposes and should be left unchanged.

How Are You Looking to Use RWD?

Browse related research, case studies and other resources that highlight examples of how RWD is being used today.

RWD Resources

COTA, Inc. Forms Strategic Real-World Data Research Partnership with the Clinical Research Data Sharing Alliance

COTA, Inc. is now a proud member of the Clinical Research Data Sharing Alliance (CRDSA). This cross-industry alliance is dedicated to accelerating the discovery and delivery of life-saving therapies through the use of high-quality clinical trials and real-world data.

Read More

What Makes a Fit-for-Purpose Database for Clinical Oncology Research?

A fit-for-purpose database includes key variables, reliable and accurate data, and representative samples that can be used to draw meaningful conclusions. RWD can be highly valuable in supporting clinical oncology research, but choosing the right data is essential. The keys to finding the right fit-for-purpose database include relevance, reliability, integrity, and bias.

Read More

How Real-World Data Helps Explore Alternative Dosing for Colorectal, Pancreatic Cancer Therapy

Research from MedStar Georgetown Lombardi Comprehensive Cancer Center and COTA shows the potential of a more patient-friendly dosing regimen for Stage 4 CRC/PC or locally advanced PC.
This collaboration highlights how real-world data can contribute to clinical research and can help answer pressing questions about care already taking place in clinical practice.

Read More

Interested in learning more about how we can transform cancer care together?

Join the Conversation

Find COTA at upcoming events, and see where we’ve been.
No event found!

Past Events


JSM 2022

Walter E. Washington Convention Center

ISPOR 2022

Gaylord National Resort & Convention Center

AUA 2022

New Orleans Ernest N. Morial Convention Center
No event found!
Load More

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.